Portage Biotech (PRTG) Key Ratios
$4.70
$-0.47
(-9.09%)
As on 05-Nov-2025 09:30EDT
Market cap
$16 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
9.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 43.41 | 72.90 | -185.24 | -212.15 | -227.90 |
| Net Profit | 17.60 | 73.64 | 40.48 | -182.34 | -263.25 |
| EPS | 19.94 | -336.20 | -364.95 | -359.90 | -292.80 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -213.79 | -134.50 | -347.11 | -188.19 | -106.07 |
| Return on Capital
| -212.38 | -133.59 | -342.98 | -188.08 | -106.07 |
| Return on Assets
| -115.81 | -73.13 | -135.29 | -140.94 | -71.21 |
| Debt to Equity (x)
| -- | -- | -- | 0.01 | -- |
Profitability
ROCE
-342.98
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-342.98
|
-188.08
|
-106.07
|
-15.14
|
-15.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-347.11
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-347.11
|
-188.19
|
-106.07
|
-15.15
|
-15.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-135.29
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-135.29
|
-140.94
|
-71.21
|
-9.13
|
-9.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
59.36
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
59.36
|
-15.70
|
49.40
|
-17.97
|
-121.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
91.02
--
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
91.02
|
27.98
|
-520.10
|
-6.55
|
-196.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.92
--
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
0.92
|
-11.82
|
-3.70
|
0.04
|
-1.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
0.01
|
--
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
0.01
|
--
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.02
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
2.02
|
2.67
|
7.33
|
31.71
|
1.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
--
|
--
|
--
|
2.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-2,472.67
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-2,472.67
|
-570.41
|
-1,752.89
|
-725.02
|
-149.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
2,556.75
|
84,372.75
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-1.47
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-1.47
|
-0.01
|
-0.52
|
-5.20
|
-21.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
-80.92
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
-80.92
|
0.14
|
0.72
|
0.72
|
3.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Portage Biotech (PRTG)
|
--
|
0.24
|
-2.78
|
-4.13
|
-23.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
